BACKGROUND Although treatment-resistant hypertension (RH) is a serious burden on
population health, there exists uncertainty about its prevalence. Hence, the objectives of this …

Objective We conducted the first systematic review and meta-analysis to estimate the
specific prevalence of apparent treatment-resistant, pseudo-resistant and true-resistant …

Background: More than a decade ago, we found that a suboptimal medication regimen was
the leading cause of resistant hypertension (RH) among patients referred to a tertiary care …

Abstract Purpose of Review Resistant hypertension (R-HTN) is related to worse
cardiovascular, renal outcomes, and death compared to non R-HTN. We aimed to review the …

Previous assessments of the prevalence of resistant hypertension (RH) in uncontrolled
blood pressure (BP) have ranged from 3% to 30%. Using real-world data, our aim was to …

J Clin Hypertens (Greenwich). 2011; 13: 523–528.© 2011 Wiley Periodicals, Inc. Resistant
hypertension is an entity that has gained a lot of attention in recent years. The prevalence …

Resistant hypertension (RH) is defined as above-goal elevated blood pressure (BP) in a
patient despite the concurrent use of 3 antihypertensive drug classes, commonly including a …

Hypertension is the most common chronic disease and the leading risk factor for disability
and premature deaths in the world, accounting for more than 9 million deaths annually …

Resistant hypertension, defined as blood pressure (BP) remaining above goal despite the
use of⩾ 3 antihypertensive medications at maximally tolerated doses (one ideally being a …

Among the vast population of hypertensive subjects, between 10 and 15% do not achieve
an adequate blood pressure (BP) control despite the use of at least three antihypertensive …